Carlisle Companies (CSL) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jan, 2026Executive summary
Achieved record adjusted EPS of $20.20 for 2024, up 30% year-over-year, with revenue growth of 9% to $5.0B and completed the strategic pivot to a pure-play building products company via the $2B sale of CIT.
Deployed nearly $700M for synergistic acquisitions (MTL, Plasti-Fab, ThermaFoam), strengthening the building envelope portfolio.
Returned $1.8B to shareholders in 2024 through $1.6B in share repurchases and $172M in dividends.
Fourth quarter 2024 revenues were $1.1B, flat year-over-year, with adjusted EPS up 7% to $4.47.
Vision 2030 targets $40 adjusted EPS, driven by innovation, M&A, and operational excellence.
Financial highlights
FY 2024 revenues reached $5.0B, with adjusted EBITDA margin at a record 26.6%, up 150 bps year-over-year.
Q4 adjusted EBITDA margin was 25.1%, down 130 bps year-over-year due to lower volumes and unfavorable mix.
Full-year free cash flow margin was 18.8%, with ROIC at 28.5%.
Net debt-to-EBITDA was 0.8x, with $754M cash and $1B available credit at year-end.
Full year operating income rose 16% to $1.14B; net income from continuing operations was $865M, up 20% year-over-year.
Outlook and guidance
2025 guidance projects mid-single-digit consolidated revenue growth and ~50 bps adjusted EBITDA margin expansion, with double-digit EPS growth targeted.
CCM segment expected to see mid-single-digit revenue growth and margin expansion; CWT segment to grow in the high-single-digit range with margin improvement from synergies and automation.
R&D expense expected to increase 50% year-over-year to support innovation.
Q1 2025 expected to be flat, with growth building through the year; price increases anticipated to take effect in Q2.
Market challenges from 2024 expected to persist into the first half of 2025, with improvement anticipated in the second half.
Latest events from Carlisle Companies
- Vision 2030 aims for $40+ EPS and $400+ share price through innovation and operational excellence.CSL
Investor presentation20 Mar 2026 - Annual meeting to address director elections, executive pay, and auditor ratification.CSL
Proxy Filing17 Mar 2026 - Proxy covers director elections, executive pay, auditor ratification, and strong governance.CSL
Proxy Filing17 Mar 2026 - 2025 saw $5.02B revenue, $1.5B returns, and 2026 targets growth and margin expansion.CSL
Q4 20254 Feb 2026 - Q2 saw 11% revenue growth, record margins, and a raised 2024 outlook on strong execution.CSL
Q2 20243 Feb 2026 - Record Q3 EPS and margin gains driven by CCM, with continued capital returns and acquisitions.CSL
Q3 202418 Jan 2026 - Strong 2024 performance and Vision 2030 strategy drive growth in building envelope solutions.CSL
Investor Presentation8 Jan 2026 - Flat Q1 revenue, robust buybacks, and positive 2025 outlook amid economic uncertainty.CSL
Q1 202520 Dec 2025 - Board recommends FOR all proposals, highlighting governance, pay-for-performance, and diversity.CSL
Proxy Filing1 Dec 2025